| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 891.46▼ | 894.44▼ | 893.30▼ | 900.30▼ | 919.48▼ |
| MA10 | 892.78▼ | 892.96▼ | 896.43▼ | 899.41▼ | 946.20▼ |
| MA20 | 893.39▼ | 897.77▼ | 902.71▼ | 922.51▼ | 930.67▼ |
| MA50 | 893.69▼ | 903.67▼ | 901.59▼ | 949.12▼ | 844.75▲ |
| MA100 | 895.30▼ | 901.35▼ | 910.93▼ | 925.12▼ | 776.94▲ |
| MA200 | 902.54▼ | 913.44▼ | 935.94▼ | 863.15▲ | 679.35▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.438▼ | -0.085▼ | -1.683▼ | -1.485▼ | -12.265▼ |
| RSI | 38.142▼ | 42.175▼ | 39.220▼ | 31.273▼ | 46.605▼ |
| STOCH | 20.995 | 60.326 | 37.146 | 27.124 | 26.889 |
| WILL %R | -85.860▼ | -66.752 | -66.752 | -81.199▼ | -88.820▼ |
| CCI | -135.532▼ | -20.260 | -72.352 | -89.144 | -179.146▼ |
| MA | $REGN Price Crossed Below MA(7) | Set Alert |
|
Thursday, April 25, 2024 10:58 AM
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent.
|
|
Thursday, April 25, 2024 08:24 AM
AbbVie (ABBV) said a study showed its drug Rinvoq was more effective in treating certain symptoms of atopic dermatitis than Sanofi (SNY) and Regeneron’s (REGN) Dupixent.
|
|
Thursday, April 25, 2024 08:15 AM
Bristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now arguably no longer part of the big pharma club. After reporting disappointing earnings figures on ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/04/24 | 912.68 | 915.00 | 877.13 | 890.68 | 576,278 |
| 24/04/24 | 906.90 | 915.70 | 904.41 | 906.54 | 373,468 |
| 23/04/24 | 905.66 | 912.74 | 903.83 | 907.32 | 340,941 |
| 22/04/24 | 904.54 | 908.50 | 897.68 | 900.16 | 335,757 |
| 19/04/24 | 914.99 | 920.73 | 891.46 | 896.82 | 501,396 |
| 18/04/24 | 901.26 | 908.81 | 892.15 | 893.99 | 446,333 |
| 17/04/24 | 903.88 | 911.6375 | 899.90 | 901.19 | 466,918 |
| 16/04/24 | 897.22 | 901.065 | 890.43 | 894.14 | 608,464 |
| 15/04/24 | 915.37 | 921.12 | 895.09 | 898.56 | 656,152 |
| 12/04/24 | 911.55 | 912.22 | 898.26 | 904.70 | 665,300 |
|
|
||||
|
|
||||
|
|